We help founders build the most disruptive companies at the
edge of Synthetic Biology and A.I. or Quantum Computing. We have designed a 6-12 months accelerator program taking
TechBio startups in pre-seed / seed stage from 0 to 1 in
leveraging AI and Quantum Computing to fast forward their
research. You build the tech in TechBio, we help you scale it.
We think that the paradigms have changed and that the convergence of Synthetic Biology and Artificial Intelligence brings an unprecedented area.
Quantum biology can potentially have a huge impact on numerous technologies, including sensing, health, the environment, and information technologies. For example, energy technologies might be revolutionized by bioinspired solar cells, and chemical, magnetic, and biological sensing technologies may be taken to a new level when applying the principles found in natural equivalents.
We have spent the last past 4 years getting to know and grow our ecosystem, as much as helping you build your vision:
We have an organic discovery process through our unique
Computing Foundation for Synthetic Biology , OpenSynBio,
which has allowed us to have more than 2,000 startups from
pre-seed to Series C aligned with our vision. This is an invite-only
program. You do not have to apply to join our programs. We are
the ones who find you, reach out to you, and get to know you until we decide to make you an offer to join us.
We will work with you closely during 6-12 months to help you
build your cloud and data operations building on some of the
best infrastruture and software service providers.
We invest capital into the startups joining our program, and more
than 1 M$ in value per startup in Cloud infrastructure and AI
training and will support your next fundraise during 18 months
by introducing you to our network of amazing investors.
Some of the most advanced Cloud , A.I., Quantum Computing services providers out-there:
Our AI x SynBio accelerator is a 6–12 months program
where we work with startups to help them go from 0 to 1 in
leveraging computing technologies to fast forward their
research and development lifecycle.
Advances in biological sciences, combined with the accelerating development of artificial intelligence (AI), are fuelling a new wave of innovation that could have significant impact in sectors across the economy, from healthcare and agriculture to consumer goods and energy.
With a market representing more than $600M per year in the United States alone, the Consumer Goods industry is poised to be disrupted, from skincare with advanced bio-designed proteins to lab-grown leather leading the way to a more sustainable retail industry.
Drugs & Therapeutics is changing and with the exponential growth of the knowledge base about cells, we are discovering, evaluating, and validating drug targets and therapeutic candidates at a faster pace that advance the next generation of immunomodulatory drugs.
The current agricultural industry relies on the massive use of fertilisers which have a significant impact on both our health and the environment. By reinventing fertilisers, synthetic biology can be used to create living products based on soil microbes.
Climate tech companies are transforming the world’s largest markets with innovative sustainable alternatives. As political capital becomes more focused on policy change surrounding global warming, and consumers demanding climate responsibility from brands, sustainable products are seeing higher growth rates than their non-sustainable alternatives.
Improving on traditional technologies like low-throughput microscopy or electrophysiological and imaging approaches, genetic techniques open the door to the development of a range of tools dedicated to the recording, control and eventually repair of neural dynamics.
Bioenergy is a sustainable and renewable form of energy derived from organic matter, such as plants, crops, food & agricultural waste. Through processes like anaerobic digestion and biomass combustion, bioenergy can provide heat, electricity, and transportation fuel while reducing greenhouse emissions.
With the world population booming, humankind cannot rely on traditional agricultural methods from 6,000 years ago; we need modern, more efficient methods - not just genetically-modified organisms and fertilisers on Earth but a new technology paradigm shift leveraging the power of micro-gravity environments to grow drugs & therapeutics in different ways and bringing the benefits back to Earth.
Poor biosecurity has destabilized most countries, took the lives of millions of people, and cost the US alone more than $10T. With a world ever so fragmented and polarized, governments will have to secure their supply chains and enhance their biodefense strategy now more than ever, thus opening the opportunity to a global market for biosecurity of over $18B by 2030.
Our vision means to support the development of the bioeconomy
worldwide and we are scaling globally to support founders from our
ecosystem in multiple locations.
We are proud of having a leading team composed of partners in Europe,US and Asia who have worked in Cloud & A.I and Synthetic Biology and have advised and mentored hundreds of startups.
We are proud of having built a large community of more than 2,000 investors - wether they are hight net worth individuals, angels, syndicates, family offices and funds - leading investments in DeepTech and TechBio in Europe, US and Asia and they are the investors we trust the more in supporting our founders on their journey. Among the many of them we want to specially feature those who accepted to connect when we were just nobodies as we believe that they have the right mindset to bet and invest in the underdogs who have crazy visions that will end up one day changing the world:
-modified-v2.png)
